Bluejay Diagnostics, Inc. 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001213900-26-053328
- Form type
- 10-Q
- CIK
- 0001704287
- Primary document
- https://www.sec.gov/Archives/edgar/data/1704287/000121390026053328/ea0289346-10q_bluejay.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bluejay Diagnostics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-1.9M | - | - |
| Net Income | $-1.9M | - | - |
| Eps Basic | -1.95 | - | - |
| Eps Diluted | -1.95 | - | - |
| Cash And Equivalents | $3.7M | - | - |
| Total Assets | $5.6M | - | - |
| Total Liabilities | $1.4M | - | - |
| Shareholders Equity | $4.2M | - | - |
| Operating Cash Flow | $-1.6M | - | - |
| Capital Expenditures | $18,989 | - | - |